🔎 Trials Near Me

Home › Astrocytoma › Texas › Houston

Astrocytoma clinical trials in Houston, TX

14 studies for Astrocytoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

RecruitingPhase 1
  • M D Anderson Cancer Center, Houston
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT03896568

Targeted Pediatric High-Grade Glioma Therapy

RecruitingObservational study
  • Texas Children's Hospital, Houston
12 Months – 39 Years · All sexes · Updated Sep 8, 2026 · NCT05839379

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

RecruitingPhase 1
  • MD Anderson Cancer Center, Houston
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388

Study of Olutasidenib and Temozolomide in HGG

RecruitingPhase 2
  • Texas Children's Hospital, Houston
Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

RecruitingPhase 3
  • MD Anderson Cancer Center, Houston
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

RecruitingPhase 1/2
  • Research Site, Houston
Ages 18 to 130 · All sexes · Updated Aug 12, 2026 · NCT05417594

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

RecruitingPhase 1
  • Excel Diagnostics & Nuclear Oncology Center, Houston
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT07733674

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

RecruitingPhase 2
  • M D Anderson Cancer Center, Houston
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT04623931

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

RecruitingEarly phase 1Healthy volunteers welcome
  • Texas Children's Hospital, Houston
Ages 1 to 21 · All sexes · Updated Jun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

RecruitingPhase 2
  • Texas Children's Hospital, Houston
12 Months – 39 Years · All sexes · Updated May 29, 2026 · NCT05843253

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

RecruitingPhase 1/2
  • Houston Methodist Neurological Institute, Houston
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT03596086

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

RecruitingPhase 1/2
  • Houston Methodist Neurological Institute, Houston
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT03603405

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

RecruitingPhase 1
  • UT MD Anderson Cancer Center, Houston
Ages 18 and older · All sexes · Updated Jun 25, 2025 · NCT05879367

Astrocytoma trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.